1. Home
  2. VZLA vs CDNA Comparison

VZLA vs CDNA Comparison

Compare VZLA & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VZLA
  • CDNA
  • Stock Information
  • Founded
  • VZLA 2017
  • CDNA 1998
  • Country
  • VZLA Canada
  • CDNA United States
  • Employees
  • VZLA N/A
  • CDNA N/A
  • Industry
  • VZLA
  • CDNA Medical Specialities
  • Sector
  • VZLA
  • CDNA Health Care
  • Exchange
  • VZLA Nasdaq
  • CDNA Nasdaq
  • Market Cap
  • VZLA 974.9M
  • CDNA 1.0B
  • IPO Year
  • VZLA N/A
  • CDNA 2014
  • Fundamental
  • Price
  • VZLA $3.26
  • CDNA $20.13
  • Analyst Decision
  • VZLA Strong Buy
  • CDNA Buy
  • Analyst Count
  • VZLA 3
  • CDNA 6
  • Target Price
  • VZLA $3.83
  • CDNA $30.33
  • AVG Volume (30 Days)
  • VZLA 4.9M
  • CDNA 866.7K
  • Earning Date
  • VZLA 07-22-2025
  • CDNA 07-30-2025
  • Dividend Yield
  • VZLA N/A
  • CDNA N/A
  • EPS Growth
  • VZLA N/A
  • CDNA N/A
  • EPS
  • VZLA N/A
  • CDNA 1.07
  • Revenue
  • VZLA N/A
  • CDNA $346,421,000.00
  • Revenue This Year
  • VZLA N/A
  • CDNA $13.31
  • Revenue Next Year
  • VZLA N/A
  • CDNA $15.46
  • P/E Ratio
  • VZLA N/A
  • CDNA $18.99
  • Revenue Growth
  • VZLA N/A
  • CDNA 25.92
  • 52 Week Low
  • VZLA $1.67
  • CDNA $14.09
  • 52 Week High
  • VZLA $3.66
  • CDNA $34.84
  • Technical
  • Relative Strength Index (RSI)
  • VZLA 59.21
  • CDNA 58.32
  • Support Level
  • VZLA $2.83
  • CDNA $18.37
  • Resistance Level
  • VZLA $3.06
  • CDNA $20.91
  • Average True Range (ATR)
  • VZLA 0.12
  • CDNA 0.80
  • MACD
  • VZLA -0.02
  • CDNA 0.06
  • Stochastic Oscillator
  • VZLA 93.41
  • CDNA 69.88

About VZLA Vizsla Silver Corp.

Vizsla Silver Corp is a junior mineral exploration and development company focused on advancing its Panuco silver-gold project located in Sinaloa, Mexico. The property contains quartz-carbonate veins with workings defining both steeply plunging and sub-horizontal ore shoots. Mineralization occurs as silver sulphides including argentite and acanthite, native gold, electrum and native silver associated with pyrite, minor galena, sphalerite and rare chalcopyrite. It has one operating segment, which is principally mineral exploration.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: